FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Susanne Bro

Research Profile

Disorders

Chemicals & Drugs

Living Beings

Procedures

Concepts & Ideas

Time Factors

Anatomy

Co-author Network

Publications

TOP 3
Tanja Xenia Pedersen; Jonas Vikeså; Susanne Bro; Christina Christoffersen; Anna Hultgårdh-Nilsson; Nanna Junker; Marie Madsen; Lars Bo Nielsen
Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
Tanja Xenia Pedersen; Sally P McCormick; Sotirios Tsimikas; Susanne Bro; Lars B Nielsen
Lipoprotein(a) accelerates atherosclerosis in uremic mice.
Susanne Bro
Cardiovascular effects of uremia in apolipoprotein E-deficient mice.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Susanne Bro (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Tanja Xenia Pedersen; Jonas Vikeså; Susanne Bro; Christina Christoffersen; Anna Hultgårdh-Nilsson; Nanna Junker; Marie Madsen; Lars Bo Nielsen
Osteopontin deficiency dampens the pro-atherogenic effect of uraemia.
Cardiovascular research 2013;98(3):352-9.
2010: Tanja Xenia Pedersen; Sally P McCormick; Sotirios Tsimikas; Susanne Bro; Lars B Nielsen
Lipoprotein(a) accelerates atherosclerosis in uremic mice.
Journal of lipid research 2010;51(10):2967-75.
2009: Susanne Bro
Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Danish medical bulletin 2009;56(4):177-92.
2009: Tanja X Pedersen; Susanne Bro; Mikkel H Andersen; Michael Etzerodt; Matti Jauhiainen; Søren Moestrup; Lars B Nielsen
Effect of treatment with human apolipoprotein A-I on atherosclerosis in uremic apolipoprotein-E deficient mice.
Atherosclerosis 2009;202(2):372-81.
2008: Susanne Bro; Allan Flyvbjerg; Christoph J Binder; Christian A Bang; Larry Denner; Klaus Olgaard; Lars B Nielsen
A neutralizing antibody against receptor for advanced glycation end products (RAGE) reduces atherosclerosis in uremic mice.
Atherosclerosis 2008;201(2):274-80.
2008: Susanne Bro; Entela Bollano; Annemarie Brüel; Klaus Olgaard; Lars B Nielsen
Cardiac structure and function in a mouse model of uraemia without hypertension.
Scandinavian journal of clinical and laboratory investigation 2008;68(7):660-6.
2007: Christian A Bang; Susanne Bro; Emil D Bartels; Tanja Xenia Pedersen; Lars B Nielsen
Effect of uremia on HDL composition, vascular inflammation, and atherosclerosis in wild-type mice.
American journal of physiology. Renal physiology 2007;293(4):F1325-31.
2007: Susanne Bro; Christoph J Binder; Joseph L Witztum; Klaus Olgaard; Lars B Nielsen
Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(5):1080-6.
2006: Susanne Bro; Rehannah Borup; Claus B Andersen; Flemming Moeller; Klaus Olgaard; Lars B Nielsen
Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.
Arteriosclerosis, thrombosis, and vascular biology 2006;26(3):570-5.
2004: Susanne Bro; Flemming Moeller; Claus B Andersen; Klaus Olgaard; Lars B Nielsen
Increased expression of adhesion molecules in uremic atherosclerosis in apolipoprotein-E-deficient mice.
Journal of the American Society of Nephrology : JASN 2004;15(6):1495-503.
2003: Susanne Bro; Jacob F Bentzon; Erling Falk; Claus B Andersen; Klaus Olgaard; Lars B Nielsen
Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice.
Journal of the American Society of Nephrology : JASN 2003;14(10):2466-74.
2003: Susanne Bro
How abnormal calcium, phosphate, and parathyroid hormone relate to cardiovascular disease.
Nephrology nursing journal : journal of the American Nephrology Nurses' Association 2003;30(3):275-81; quiz 282-3.
2001: Bengt Rippe; Ole Simonsen; O Heimbürger; Anders Christensson; Borje Haraldsson; G Stelin; L Weiss; F D Nielsen; Susanne Bro; M Friedberg; Anders Wieslander
Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.
Kidney international 2001;59(1):348-57.
1999: Susanne Bro; Jakob B Bjorner; P Tofte-Jensen; S Klem; B Almtoft; H Danielsen; M Meincke; M Friedberg; Bo Feldt-Rasmussen
A prospective, randomized multicenter study comparing APD and CAPD treatment.
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1999;19(6):526-33.
1998: Lisbet Brandi; Palle K Nielsen; Susanne Bro; H Daugaard; Klaus Olgaard
Long-term effects of intermittent oral alphacalcidol, calcium carbonate and low-calcium dialysis (1.25 mmol L-1) on secondary hyperparathyroidism in patients on continuous ambulatory peritoneal dialysis.
Journal of internal medicine 1998;244(2):121-31.
1998: Susanne Bro; R A Rasmussen; J Handberg; Klaus Olgaard; Bo Feldt-Rasmussen
Randomized crossover study comparing the phosphate-binding efficacy of calcium ketoglutarate versus calcium carbonate in patients on chronic hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(2):257-62.
1997: Susanne Bro; Lisbet Brandi; H Daugaard; Klaus Olgaard
Calcium concentration in the CAPD dialysate: what is optimal and is there a need to individualize?
Peritoneal dialysis international : journal of the International Society for Peritoneal Dialysis 1997;17(6):554-9.
1997: Susanne Bro; Klaus Olgaard
PTH--one can teach an old hormone new tricks.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(11):2222-4.
1997: Susanne Bro; Klaus Olgaard
Effects of excess PTH on nonclassical target organs.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1997;30(5):606-20.
1996: Susanne Bro; Lisbet Brandi; Klaus Olgaard
High-normal calcium (1.35 mmol/l) dialysate in patients on CAPD: efficient and safe long-term control of plasma calcium, phosphate, and parathyroid hormone.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11(8):1586-91.
1996: Susanne Bro; Lisbet Brandi; Klaus Olgaard
Risk/benefit in prophylaxis and treatment of secondary hyperparathyroidism. A comparison of two low calcium peritoneal dialysis fluids.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1996;11 Suppl 3():47-9.
1994: Klaus Olgaard; E Lewin; Susanne Bro; H Daugaard; M Egfjord; V Pless
Enhancement of the stimulatory effect of calcium on aldosterone secretion by parathyroid hormone.
Mineral and electrolyte metabolism 1994;20(5):309-14.
1993: S S Pedersen; Susanne Bro; P Schlichting; Hendrik Vilstrup; Preben Kirkegaard; Jens Kondrup
[Plasmapheresis as life-saving treatment in acute hepatic failure].
Ugeskrift for laeger 1993;155(10):691-4.